Back to 
MORGAN STANLEY
MORGAN STANLEY
RARE8 quarters
Position history for MORGAN STANLEY's holdings in ULTRAGENYX PHARMACEUTICAL IN
MORGAN STANLEY holds 1.5M shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), worth $31.4M as of 2026-Q1. The position was decreased (-17.8% shares). RARE represents 0.0% of MORGAN STANLEY's portfolio.
Current Value
$31.4M
Current Shares
1.5M
Total Value Change
+$11M
Total Shares Change
+1M
Quarter-by-Quarter History
Other major holders of RARE: Capital Research Global Investors, Capital International Investors, FEDERATED HERMES, INC.